Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: World of Books (was SecondSale), Montgomery, IL, USA
Zustand: Very Good. Item in very good condition! Textbooks may not include supplemental items i.e. CDs, access codes etc.
Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: World of Books (was SecondSale), Montgomery, IL, USA
Zustand: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc.
Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
EUR 5,89
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 20,88
Anzahl: 15 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 25,16
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. 264.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 24,21
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 264 pages. 9.25x6.25x0.75 inches. In Stock.
Sprache: Englisch
Verlag: Princeton University Press, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2021. Paperback. . . . . . Books ship from the US and Ireland.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 31,74
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 264 pages. 9.25x6.25x0.75 inches. In Stock.
Anbieter: moluna, Greven, Deutschland
EUR 27,46
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Über den AutorVictoria Ivashina is the Lovett-Learned Professor of Finance at Harvard Business School. Josh Lerner is the Jacob H. Schiff Professor of Investment Banking at Harvard Business School and the author of, am.
Sprache: Englisch
Verlag: Princeton University Press Apr 2021, 2021
ISBN 10: 0691217084 ISBN 13: 9780691217086
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - How to overcome barriers to the long-term investments that are essential for solving the worlds biggest problems There has never been a greater need for long-term investments to tackle the worlds most difficult problems, such as climate change and decaying infrastructure. And it is increasingly unlikely that the public sector will be willing or able to fill this gap. If these critical needs are to be met, the major pools of long-term, patient capitalincluding pensions, sovereign wealth funds, university endowments, and wealthy individuals and familieswill have to play a large role. In this accessible and authoritative account of long-term capital investment, two leading experts on the subject, Harvard Business School professors Victoria Ivashina and Josh Lerner, highlight the significant hurdles facing long-term investors and propose concrete ways to overcome these difficulties. Presenting the best evidence in an engaging way by using memorable stories and examples, Patient Capital describes how large investors increasingly want and need long-run investments that have the potential to deliver greater returns than those in the public markets. Yet success in such investments has been the exception. Performance has suffered from both the limitations of investors and the internal structure of their fund managers, often resulting in the wrong incentives and a lack of long-term planning. Yet the challenges facing long-term investors can be surmounted and the rewards are potentially large, both for investors and society as a whole. Patient Capital shows how to make long-term investment work better for everyone.